Literature DB >> 33315653

Immunopathogenesis of skin injury in systemic lupus erythematosus.

Grace A Hile1, J Michelle Kahlenberg1,2.   

Abstract

PURPOSE OF REVIEW: Skin injury is the most common clinical manifestation of SLE and is disfiguring, difficult to treat, and incompletely understood. We provide an overview of recently published articles covering the immunopathogenesis of skin injury in SLE. RECENT
FINDINGS: Skin of SLE has an inherent susceptibility to apoptosis, the cause of which may be multifactorial. Chronic IFN overexpression leads to barrier disruption, infiltration of inflammatory cells, cytokine production, and release of autoantigens and autoantibody production that result in skin injury. Ultraviolet light is the most important CLE trigger and amplifies this process leading to skin inflammation and potentially systemic disease flares.
SUMMARY: The pathogenesis of skin injury in CLE is complex but recent studies highlight the importance of mechanisms driving dysregulated epidermal cell death likely influenced by genetic risk factors, environmental triggers (UV light), and cytotoxic cells and cellular signaling.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33315653      PMCID: PMC8208233          DOI: 10.1097/BOR.0000000000000770

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  92 in total

1.  U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7.

Authors:  Emina Savarese; Ohk-wha Chae; Simon Trowitzsch; Gert Weber; Berthold Kastner; Shizuo Akira; Hermann Wagner; Roland M Schmid; Stefan Bauer; Anne Krug
Journal:  Blood       Date:  2005-12-20       Impact factor: 22.113

2.  Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions.

Authors:  H Kanauchi; F Furukawa; S Imamura
Journal:  J Invest Dermatol       Date:  1991-04       Impact factor: 8.551

3.  Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus.

Authors:  P Rahman; D D Gladman; M B Urowitz
Journal:  J Rheumatol       Date:  1998-09       Impact factor: 4.666

4.  The intracellular 52-kd Ro/SSA autoantigen in keratinocytes is up-regulated by tumor necrosis factor alpha via tumor necrosis factor receptor I.

Authors:  Velia Gerl; Björn Hostmann; Christa Johnen; Aderajew Waka; Markus Gerl; Frank Schumann; Rolf Klein; Andreas Radbruch; Falk Hiepe
Journal:  Arthritis Rheum       Date:  2005-02

5.  SSA/Ro antigen expressed on membrane of UVB-induced apoptotic keratinocytes is pathogenic but not detectable in supernatant of cell culture.

Authors:  B Wang; X Dong; Z Yuan; Y Zuo; J Wang
Journal:  Chin Med J (Engl)       Date:  1999-06       Impact factor: 2.628

Review 6.  Recent insights into the genetic basis of systemic lupus erythematosus.

Authors:  Ornella Josephine Rullo; Betty P Tsao
Journal:  Ann Rheum Dis       Date:  2012-12-19       Impact factor: 19.103

7.  Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients.

Authors:  E Reefman; H Kuiper; P C Limburg; C G M Kallenberg; M Bijl
Journal:  Ann Rheum Dis       Date:  2008-01       Impact factor: 19.103

8.  High Ro52 expression in spontaneous and UV-induced cutaneous inflammation.

Authors:  Vilija Oke; Ismini Vassilaki; Alexander Espinosa; Linn Strandberg; Vijay K Kuchroo; Filippa Nyberg; Marie Wahren-Herlenius
Journal:  J Invest Dermatol       Date:  2009-02-05       Impact factor: 8.551

9.  Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light.

Authors:  A Köck; T Schwarz; R Kirnbauer; A Urbanski; P Perry; J C Ansel; T A Luger
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  New Treatments for Systemic Lupus Erythematosus on the Horizon: Targeting Plasmacytoid Dendritic Cells to Inhibit Cytokine Production.

Authors:  Laura M Davison; Trine N Jorgensen
Journal:  J Clin Cell Immunol       Date:  2017-12-20
View more
  3 in total

1.  [Immunopathogenesis of systemic lupus erythematosus].

Authors:  Martin Aringer; Stephanie Finzel; Reinhard E Voll
Journal:  Z Rheumatol       Date:  2022-05-13       Impact factor: 1.372

2.  Targeting of EIF4EBP1 by miR-99a-3p affects the functions of B lymphocytes via autophagy and aggravates SLE disease progression.

Authors:  Meng Yang; Binbin Yang; Danqi Deng
Journal:  J Cell Mol Med       Date:  2021-10-20       Impact factor: 5.310

Review 3.  The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases.

Authors:  Madhu Ramaswamy; Raj Tummala; Katie Streicher; Andre Nogueira da Costa; Philip Z Brohawn
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.